Skip to main content
. 2024 Apr 20;16(8):1228. doi: 10.3390/nu16081228

Table 1.

Initial characteristics of participants according to study group.

Gluten Group (n = 17) Placebo Group (n = 29) p
Age (mean ± standard deviation) 41.59 ± 9.24 41.28 ± 8.93 0.910
Sex, n (%)
 Women 11 (64.7) 25 (86.2) 0.139
 Men 6 (35.3) 4 (13.8)
Body mass index, (median (interquartile range)) 23.8 (21.4–27.8) 24.6 (22.95–27.05) 0.482
Gastrointestinal (GI) symptoms , n (%)
 Abdominal pain 15 (88.2) 22 (75.9) 0.450
 Bloating 12 (70.6) 26 (89.7) 0.125
 Flatulence 15 (88.2) 27 (93.1) 0.619
 Diarrhea 9 (52.9) 13 (44.8) 0.761
 Stomach sounds 11 (64.7) 24 (82.8) 0.282
 Constipation 6 (35.3) 11 (37.9) 1
 Urge to defecate 9 (52.9) 16 (55.2) 1
 Incomplete evacuation 9 (52.9) 21 (72.4) 0.213
 Nausea 10 (58.8) 6 (20.7) 0.012
 Burning 8 (47.1) 14 (48.3) 1
 Belching 9 (52.9) 15 (51.7) 1
 Acid regurgitation 6 (35.3) 9 (31) 1
 Epigastric pain 8 (47.1) 13 (44.8) 1

The initial number of samples was low for certain microbiota and biochemical tests due to lack of complete data.